M1 and M8 homeopathic complex have been use as adjuvant therapy for cancer patients.

Background: Cancers are complex diseases rated among the top 10 causes of death worldwide. The Laboratory of Inflammatory and Neoplastic Cells at Federal University of Parana have been studied the effects of several highly diluted solutions in cell-based models over de the past decade. Among those solutions, M1 and M8 are highly diluted tinctures complex which act as biological response modifiers. Both complexes turned to be promising compounds to use as adjuvant therapy for selected cancer patient. As a private physician, over the last ten years, many cancer patients have been reached our clinic looking forward homeopathic medicines that could be used as complimentary therapy to their standard cancer treatment. The types of cancer, as well the stages of the disease, among those patients were quite heterogeneous. We have followed not only those who have detected the cancer in an early stage, but also people who have been discouraged, once they’ve been told as a patient without therapeutic possibility. Aims: To exchange observations and outcomes in the disease’s natural history of cancer patients who have been treated with M1 and M8 as adjuvant therapy to the standards treatments. Methodology: The prescription of the treatment was based on primary situ of the disease as well the standard treatment which was been followed by the patient at the time of the attendance. It varied from one complex alone, three times a day, to the use of both complexes, six times a day. Results and discussion: Many cancer patients who were undergoing chemotherapy reported the side effects of that treatment had become mild in comparison to the time they were not using the complexes. Other interesting outcome was the fact that, for some patients who were skipping chemotherapy sessions due to neutropenia, the standard treatment could be followed as planed after start to use M8. Patients who did surgical procedures reported a better healing process, with less scars, when they compared their own evolution to other patients who attend same oncologic facility. Conclusion: Although M1 and M8 act as biological response modifiers and their use as adjuvant therapy for cancer patients is a promising approach, the fact that cancer is complex disease, which requires a multiple approach, brings an ethical consideration on use or not use complimentary therapies as adjuvant treatments. Our private practice showed up in the last decade that cancer patients can benefit from the use of those highly diluted complexes, adjuvant to standard treatments as chemotherapy and surgery.

Rosa Einhorn (1872–1950): A Woman Pioneer in Medicine between Bosnia (1902–1913), New York, and Palestine

<p>This short biography details the life and medical activities of Rosa Einhorn, mariée Bloch (1872–1950), who practised as an Austro-Hungarian (AH) official female physician in Travnik in occupied Bosnia and Herzegovina (BH) from 1902 to 1904, and as a semi-official private physician from 1905 to 1912/13. Born in Hrodna district in the Russian Pale of Crescent, Einhorn had qualified and practised as a “<em>feldsheritsa</em>” in Russia and went to Switzerland to study medicine in 1896. Upon receiving her medi­cal doctorate from the University of Lausanne in 1901, she became recommended as a particularly adequate candidate for the not-yet-created position of an AH official female physician in BH. After Einhorn functioned as a general practitioner for women and children in Travnik and the adjacent districts for two years, the AH public health authorities officially dismissed her due to her engagement and marriage to the AH judiciary Sigismund Bloch (1850–1927). However, she obtained a right to private practice in 1905 and was employed as a private physician in AH anti-syphilis campaigning. Struggling for her reinstatement as an official female physician in Travnik, she also strove for the accreditation of her Swiss diploma in Austria, though in vain. After two attempts to emigrate to the United States in 1904 and 1913, Rosa Einhorn finally left Europe to work as a physician in the United States and Mandatory Palestine/Eretz Israel in 1923. She died in New York on May 27, 1950.</p><p><strong>Conclusion. </strong>Rosa Einhorn was employed as a provisory official female physician in Travnik in 1903/1904, the AH authorities accepting her only as a lo­cal private female physician after her marriage in 1905. Struggling in vain for her reinstatement, she finally left Bosnia in 1913.</p>

Development of a centralized, remote clinical pharmacy service to enhance primary care

More than 50% of Americans possess at least one chronic condition and another 25% suffer from two or more, leaving primary care teams tasked to care for the chronic, acute, and preventive care needs of their large patient panels. Pharmacists can reduce the burden on busy providers by effectively managing chronic diseases as members of health care teams. Many private physician practices lack the resources to include pharmacists on their teams. A centralized, remote clinical pharmacy services model allows pharmacists to remotely manage chronic disease in patients in collaboration with primary care providers. The purpose of this report is to describe how a centralized, remote clinical pharmacy team was developed, trained, and effectively integrated into multiple, diverse primary care settings across the U.S.

PONSETI METHOD IN BRAZIL: FIRST TEN YEARS OF A CLUBFOOT WEBSITE - USERS PROFILE

ABSTRACT Objective: To analyze the profiles of the individuals who access the website regarding congenital clubfoot (CC) information and the first ten years of Ponseti method implementation in Brazil. Methods: This is a retrospective documentary study, with quantitative database analysis, from 2002 to 2012. Parents or caregivers completed a semi-structured questionnaire regarding the main difficulties encountered, the search for different professionals in the area, and what were the main questions the reader might have when searching on a technical website. Results: In total, 94% of participants had a family member or acquaintance with CC, most participants were women (74%), higher education level (40%), married (75%), income above one minimum wage (80%), working in administrative positions (21%,) and living in the urban area (99%). Of the participants, 44% sought three or more physicians at the beginning of treatment, and an average of 77% of the participants used health insurance or a private physician. Conclusion: The participants’ profile regarding CC is composed of women, married, living in urban areas, predominantly from Southeastern Brazil, higher education level, with income above 1.5 minimum wages, and who were treating their children with a private physician. Level of Evidence II, Retrospective study.

Gisela Januszewska (née Rosenfeld), an Austro- Hungarian ‘Woman Doctor for Women’ in Banjaluka, 1899–1912

<p>The focus of this article is on the biography and medical activity of Gisela Januszewska (nee Rosenfeld) in Austro-Hungarian (AH) occupied Bosnia and Herzegovina (BH) between 1899 and 1912. Rosenfeld, later Januszewska and then Kuhn(ova) by marriage, was the fifth of a total of nine official female physicians who were employed by the AH administration to improve the health and hygienic conditions among Bosnian and Bosnian Muslim women. In 1893, Gisela Kuhn moved from Brno, Moravia to Switzerland to pursue her medical studies; she was awarded her Doctorate in Medicine (MD) from the University of Zurich in 1898. In the same year, she took up her first position as a local health insurance doctor for women and children in Remscheid but was prohibited from practising in the German Empire. In 1899, she successfully applied to the AH authorities for the newly established position of a female health officer in Banjaluka and began working there in July 1899. She lost her civil service status upon marrying her colleague, Dr Wladislaw Januszewski, in 1900 but carried out her previously officially assigned tasks as a private physician. In 1903, she was employed as a ‘woman doctor for women’ at the newly established municipal outpatient clinic in Banjaluka. Upon her husband’s retirement in 1912, the couple left BH and settled in Graz, Styria. After, World War I Januszewska ran a general medical practice in Graz until 1935 and worked as a health insurance-gynaecologist until 1933. She received several AH and Austrian awards and medals for her merits as a physician and a volunteer for humanitarian organisations. Upon Austria’s annexation to Nazi Germany 1938, however, she was classified a Jew and was deported to Theresienstadt concentration camp (Terezin, Bohemia), where she died in 1943.</p><p><strong>Conclusion. </strong>Gisela Januszewska, nee Rosenfeld (1867–1943) viewed her medical practice as a social medicine mission which she put into practice as a ‘woman doctor for woman’ in Banjaluka, BH (1899–1912) and Graz, Austria (1919–1935).</p>

Demetrius Zambaco Pasha (1832–1913): The first leprologist of the Orient

Démétrius Zambaco Pasha (1832–1913) was an internationally renowned Ottoman-born French dermatologist of Greek origin who is considered the first leprologist of the Orient. A graduate from the Faculty of Medicine in Paris, he practised there until he returned to Istanbul in 1872 and later served as a private physician to the Ottoman sultan Abdul Hamid II (1842–1918), then Abbas Hilmi Pasha (1874–1944), the last Khedive of Egypt. Dr Zambaco produced numerous publications in a variety of medical subjects including leprosy, syphilis, morphinomania, eunuchs, and medical history. Leprosy, however, was his main field of scientific interest, with nearly 40 studies published and many other communications presented at international medical congresses. Due to his outstanding scientific contributions, Dr Zambaco garnered many accolades including the Cholera Medal of Honour, the Montyon Prize, and Légion d’Honneur from France as well as the honorary title of Pasha, a higher rank in the political and military system, from the Ottoman Empire.

Surgeon specialist branding or what do surgeon specialists need to know about their brand

As the world has widely adapted the principle of searching for relevant information online, many practicing physicians, especially those who are involved in specialty - must pay a close attention to their brand and their reputation on the World Wide Web. There are numerous web pages available to the general public about particular physician and where he/she practices. Most of those pages are either managed by a third-party company or created for promotional use. Some physicians are not even aware of this and are found by surprise when their patients bring up the information, they found on them online. Physician’s name is a brand that he or she carries throughout entire medical career, and it might make or break the legacy of academic or private physician on the long run.

RELEVANT ISSUES OF THE CRIMINAL LIABILITY OF THE PRIVATE DOCTORS FOR CORRUPTION CRIMES

Introduction: Corruption, as a socio-economic problem, is characteristic of every society. The aim: To study relevant issues of criminal liability of the private doctors for committing corruption crimes. Materials and methods: In the article general scientific and special-scientific methods of cognition wer eused which provided an objective analysis of the research purpose. Review: The article analyzes actual questions of relenant issues of criminal liability of the private doctors for committing corruption crimes. The authors propose to research the criminal responsibility of this specific subject through the prism of the crime, as well as it’s elements. Thus, special attention is focused on the analysis of thees sence of the object of the crimes, the responsibility for which provided in. Art. 365-2 and 368-4 of the Criminal Code of Ukraine. Inaddition, the concept of “unlawful profit” is investigated, in the context of comparison with the “bribe”. Thees sence of the objective side of corruption crimes, the subject of which is a private doctor, is explained in detail. In particular, the concepts of “authority”, “offer”, “promise”, etc. Particul arattention is paid to analyzing the legal status of a private doctor as a person authorized to provide public services. The authors focus on the analysis of the subjective side of thes corruption crimes being studied by a private physician. All penalties that can be applied to a private doctor for committing corrupt acts are systematized. At the very end, the issue of the totality of crimes is investigated. Conclusions: Bringing a private doctor in the responsibility for committing a corrupt act is difficult in there gion, because the criminalization of corruptionactions of suchpersons took place relatively recently, therefore, pre-trial investigation bodies have not yet established a well-established system of tactical and methodological actions that would facilitate this process.